FDA Drug Application (020725) for CREON by ABBVIE

Back to FDA Applications sponsored by ABBVIE

Application Number020725
Product Number001
FormCAPSULE, DELAYED RELEASE;ORAL
Dosage30,000USP UNITS;6,000USP UNITS;19,000USP UNITS
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameCREON
Active IngredientPANCRELIPASE (AMYLASE;LIPASE;PROTEASE)

Active IngredientCount
List of drugs with Active Ingredient AMYLASE7
List of drugs with Active Ingredient LIPASE7
List of drugs with Active Ingredient PANCRELIPASE7
List of drugs with Active Ingredient PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)7
List of drugs with Active Ingredient PROTEASE7


Back to FDA Applications sponsored by ABBVIE